GT Biopharma
GTBP
GTBP
58 hedge funds and large institutions have $12.9M invested in GT Biopharma in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 28 reducing their positions, and 8 closing their positions.
Holders
58
Holders Change
+3
Holders Change %
+5.45%
% of All Funds
0.92%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
6
Reduced
28
Closed
8
Calls
$156K
Puts
$135K
Net Calls
+$21K
Net Calls Change
-$74K
Top Buyers
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$2.85M |
| 2 |
2
Two Sigma Investments
New York
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$768K |
| 4 |
4
Renaissance Technologies
New York
|
$537K |
| 5 |
5
Two Sigma Advisers
New York
|
$53K |
